Old Web
English
Sign In
Acemap
>
authorDetail
>
Klaus Heissner
Klaus Heissner
Martin Luther University of Halle-Wittenberg
Medicine
General surgery
Soft tissue sarcoma
Pazopanib
Gemcitabine
4
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumors
2020
Current Opinion in Clinical Nutrition and Metabolic Care
Philipp Ivanyi
Hendrik Eggers
Mareike Hornig
Bernd Kasper
Klaus Heissner
Hans-Georg Kopp
Martha M. Kirstein
Arnold Ganser
Viktor Grünwald
Show All
Source
Cite
Save
Citations (1)
Pazopanib vs pazopanib + gemcitabine in refractory soft tissue sarcoma: A randomized phase II trial of the AIO.
2016
Journal of Clinical Oncology
Hans-Joachim Schmoll
Jörn Rüssel
Peter Reichardt
Lars H. Lindner
Hans-Georg Kopp
Alexander Stein
Franziska Cygon
Klaus Heissner
Show All
Source
Cite
Save
Citations (4)
Pazopanib vs pazopanib / gemcitabine in refractory soft tissue sarcoma: The AIO-STS-009-trial
2016
Onkologie
Joern Ruessel
Regine Mayer-Steinacker
Lars H. Lindner
Bernd Kasper
Hans-Georg Kopp
T. Kessler
Franziska Cygon
P. Reichard
Fabian Maximilian Meinert
Alexander Stein
Martina Crysandt
Dietger Niederwieser
Annegret Kunitz
Gerlinde Egerer
E. Eigendorff
H. J. Schmoll
Klaus Heissner
Jörg Steighardt
Show All
Source
Cite
Save
Citations (0)
Current Treatment of Stage I Testicular Seminoma
2011
Onkologie
Hans-Joachim Schmoll
Klaus Heissner
Show All
Source
Cite
Save
Citations (0)
1